Investigating new imaging criteria for non-operative treatment following neoadjuvant chemoradiation in rectal cancer patients

eiden Unversity Medical Center0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年2月28日

试验速览

暂无简介。

•Biopsy proven adenocarcinoma of the rectum
•Patients with locally advanced rectal cancer who, according to current guidelines, are eligible for treatment with neoadjuvant chemoradiation
•Patients treated in the LUMC, HMC, Alrijne Leiderdorp or Groene Hart Ziekenhuis Gouda.
•Age 18 years and older;
•Willing to participate in all aspects of the study

•Patients with rectal cancer, receiving chemoradiation as part of the TESAR trial
•Diabetes mellitus
•Claustrofobia (low dose benzodiazepines are allowed)
•Prior radiotherapy to the pelvis
•If female and fertile: signs and symptoms of pregnancy or a positive pregnancy test / breast-feeding (a formal negative pregnancy test is not obligatory
•Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
•Contraindications for Magnetic Resonance Imaging
•Patient has evidence of infection in the 14 days prior to the FDG-PET/CT scan localised to the lower abdomen, pelvic region, lower back, inguinal region
•Inability to tolerate lying supine for the duration of an FDG-PET/CT examination (~30min)

发起方

eiden Unversity Medical Center